Standardized Computer-Assisted Analysis of PRAME Immunoreactivity in Dysplastic Nevi and Superficial Spreading Melanomas
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms24076388 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Elias A T Koch und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Uniklinikum Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), 91054 Erlangen, Germany. Hauptthemen laut MEDLINE: Dysplastic Nevus Syndrome, Skin Neoplasms, Melanoma, Nevus. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
PRAME (PReferentially expressed Antigen in MElanoma) is a cancer testis antigen that is frequently expressed in melanoma compared to benign melanocytic proliferations and nevi. However, the interpretation of the intensity and distribution of PRAME immunostaining is not standardized a lot, which makes interpretation difficult. PRAME-stained histological slides of superficial spreading melanomas (SSM) and dysplastic nevi (DN) were digitized and analyzed using the digital pathology and image platform QuPath. t-tests and ROC AUCs were performed with SPSS. A p-value of 0.8 was considered a good result. A cut-off score was defined in an evaluation cohort and subsequently analyzed in an independent validation cohort. In total, 81 PRAME-stained specimens were included. The evaluation cohort included 32 (50%) SSM and 32 (50%) DN, and the mean of PRAME-positive cells/mm2 for the entire lesion was 455.3 (SD 428.2) in SSM and 60.5 (SD 130.1; p < 0.001) in DN. The ROC AUC of PRAME-positive cells of the entire lesion was 0.866, and in the epidermis it was 0.901. The defined cut-off score to distinguish between DN and SSM was 97.67 cells/mm2. In the validation cohort, 16 out of 17 cases (94.1%) were correctly classified by the cut-off score. The computer-aided assessment of PRAME immunostaining is a useful tool in dermatopathology to distinguish between DN and SSM. Lesions with a moderate expression and indifferent morphologic features will remain a challenge for dermatopathologists.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Uniklinikum Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), 91054 Erlangen, Germany.
- Comprehensive Cancer Center Erlangen-European Metropolitan Area of Nuremberg (CCC ER-EMN), 91054 Erlangen, Germany.
- MVZ Pathology, Sozialstifung Bamberg, 96049 Bamberg, Germany.
ORCID-Profile: Elias A T Koch, Michael Erdmann, Markus V Heppt
Zitieren
APA
Koch, E. A. T., Erdmann, M., Berking, C., Kiesewetter, F., Kramer, R., Schliep, S., & Heppt, M. V. (2023). Standardized Computer-Assisted Analysis of PRAME Immunoreactivity in Dysplastic Nevi and Superficial Spreading Melanomas. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24076388
Vancouver
Koch EAT, Erdmann M, Berking C, Kiesewetter F, Kramer R, Schliep S, et al. Standardized Computer-Assisted Analysis of PRAME Immunoreactivity in Dysplastic Nevi and Superficial Spreading Melanomas. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24076388
BibTeX
@article{Koch2023,
author = {Koch, Elias A T and Erdmann, Michael and Berking, Carola and Kiesewetter, Franklin and Kramer, Rafaela and Schliep, Stefan and Heppt, Markus V},
title = {Standardized Computer-Assisted Analysis of PRAME Immunoreactivity in Dysplastic Nevi and Superficial Spreading Melanomas},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms24076388}
}
EUVIMED